Findings from a Dartmouth study, led by Taressa Fraze, PhD, offer new details about how Accountable Care Organizations (ACOs) are using home visits to improve care management and identify patient needs while aiming to reduce costs. The study was part of a broader research effort at Dartmouth focused on how ACOs care for patients with complex clinical and social needs.
Articles by: Timothy Dean
Geisel Researchers to Receive $2.6 Million Award to Study Pediatric Hospital Admissions
A Geisel research team led by JoAnna Leyenaar has been approved for a $2.6 million award to compare the effectiveness of direct admission and admission through emergency departments for hospitalized children.
Dartmouth Study Links State Tax Spending to Middle-Aged Mortality Rates
There is a strong association between the amount that U.S. states spend on their residents through statewide taxation and state government expenditures and middle-aged mortality rates, according to a new Dartmouth study in the journal PLOS One.
Study Finds that Quitting Smoking During Pregnancy Lowers Risk of Preterm Births
There is an important association between maternal cigarette smoking cessation during pregnancy and risk of preterm birth, according to a new Dartmouth-led study published in JAMA Network Open.
O’Malley Receives Distinguished Award for Scientific Excellence
James O’Malley, MS, PhD, a professor of The Dartmouth Institute for Health Policy and Clinical Practice and of biomedical data science at the Geisel School of Medicine and director of the Program in Quantitative Biomedical Sciences, has received the 2019 ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Award for Excellence in Health Economics and Outcomes Research Methodology.
Dartmouth Researchers Offer New Insights into How Maternal Immunity Impacts Neonatal HSV
Findings from a Dartmouth-led study published in the journal Science Translational Medicine, are offering new insights into neonatal herpes, its impact on developing nervous systems, and how newborns can be protected from the disease. In this innovative study, investigators were able to measure not only mortality but also neurological consequences of infection in mice who acquired the virus.
STEM Program Helps High Schoolers Make Connections, See What’s Possible
Geisel first-year students and Sweitzer Fellows Shuaibu Ali ’21 and Kenny Williams ’21 are partnering with classmates and local high schools to offer Upper Valley STEM Scholars. The program allows students to gain exposure and mentorship in STEM fields like medicine, while learning how societal issues impact the health of communities.
Anne Schuchat, MD, to Speak at Geisel’s Class Day Ceremony
Anne Schuchat MED ’84, the principal deputy director of the Centers for Disease Control and Prevention (CDC) and a retired rear admiral from the Commissioned Corps of the U.S. Public Health Service (USPHS), will be the featured speaker at Geisel’s 2019 Class Day Ceremony, which will be held Saturday, June 1 at the Hopkins Center’s Spaulding Auditorium.
SYNERGY Informatics Workshop on i2b2 March 22
Have you been wondering if there are enough eligible patients to support your study? Find out using Dartmouth i2b2—the patient cohort discovery tool! SYNERGY Clinical and Translational Science Institute will provide an overview of i2b2 this Friday, March 22 from 9:00 to 10:00 AM in Auditorium H at DHMC (includes a light breakfast).
Part of the SYNERGY Spring Research Informatics Workshop Series, the session will include a basic introduction, sample queries, and how to get an account. To register, go to: https://is.gd/Information_Request.
To see the full schedule of workshops, visit: https://synergy.dartmouth.edu/i2b2-redcap-workshops-spring-2019
Spring Workshop Series by SYNERGY
This spring, SYNERGY Clinical and Translational Science Institute will be running a series of workshops at Dartmouth-Hitchcock (from March 22 through May 31) for two informatics tools: REDCap and i2b2. REDCap is a secure web application for building and managing online surveys and data. Dartmouth i2b2, the patient cohort discovery tool, will allow you to answer questions like: Are there enough eligible patients to support my study? How many patients are taking a certain medication? For how long?